Abstract
The kalimantacins are a family of hybrid polyketide-nonribosomal peptide derived natural products that display potent and selective antibiotic activity against multi-drug resistant strains of Staphylococcus aureus. Herein, we report the first total synthesis of kalimantacin A, in which three fragments are prepared and then united via Sonogashira and amide couplings. The enantioselective synthetic approach is convergent, unlocking routes to further kalimantacins and analogues for SAR studies and clinical evaluation.
Original language | English |
---|---|
Pages (from-to) | 6349-6353 |
Number of pages | 5 |
Journal | Organic Letters |
Volume | 22 |
Issue number | 16 |
Early online date | 10 Aug 2020 |
DOIs | |
Publication status | Published - 21 Aug 2020 |
Structured keywords
- BrisSynBio
- Bristol BioDesign Institute
- BCS and TECS CDTs